MRK vs WST
By Alex · Tickerpine
Merck & Co., Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | WST |
|---|---|---|
| Price | $145.27 | $392.15 |
| Market cap | $358.41B | $27.60B |
| P/E ratio | 117.2 | 50.1 |
| ROE | 6.96% | 19.09% |
| Profit margin | 4.77% | 16.98% |
| Revenue growth | 5.10% | 13.80% |
| Dividend yield | 2.34% | 0.27% |
| Beta | 0.22 | 1.12 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs WST in plain English
- MRK is the bigger company — about 13.0× the market cap of WST.
- WST is cheaper on earnings (P/E 50.1 vs 117.2).
- WST earns a higher return on equity (19% vs 7%).
- WST is growing revenue faster (14% vs 5%).
- MRK has the higher dividend yield (2.34% vs 0.27%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.